Skip to main content
Clinical Trials/NCT05224830
NCT05224830
Completed
Not Applicable

A Cross-sectional Study : Is There a Relationship Between Hyperventilation Syndrome and History of Acute SARS-CoV-2 Infection?

Central Hospital, Nancy, France1 site in 1 country2,846 target enrollmentJanuary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID-19
Sponsor
Central Hospital, Nancy, France
Enrollment
2846
Locations
1
Primary Endpoint
Assess the relationship between a hyperventilation syndrome and previous acute SARS-CoV-2 infection.
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Following an acute COVID-19 infection, many patients suffer from long lasting physical symptoms that may greatly impair quality of life. Persisting dyspnea and other functional respiratory complaints could evoke Hyperventilation Syndrome (HVS) as a putative contributor of the long-COVID presentation in COVID-19 survivors. We aimed to assess the possible relationship between a HVS and previous acute SARS-CoV-2 infection.

Registry
clinicaltrials.gov
Start Date
January 1, 2021
End Date
July 1, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Central Hospital, Nancy, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Read and speak French
  • Perform a pulmonary function test

Exclusion Criteria

  • incomplete questionnaire or inability to obtain an interpretable lung function assessment

Outcomes

Primary Outcomes

Assess the relationship between a hyperventilation syndrome and previous acute SARS-CoV-2 infection.

Time Frame: Nijmegen questionnaire during 15 minutes (cross-sectional monocentric study)

Secondary Outcomes

  • Assess the relationship between a hyperventilation syndrome and dyspnea(Nijmegen questionnaire during 15 minutes (cross-sectional monocentric study))

Study Sites (1)

Loading locations...

Similar Trials